Industry Readies For Round Two Of EU Patent Directive 19/01/2006 by William New, Intellectual Property Watch 5 Comments Prague — Patent-dependent industries that spent heavily for lobbying on a failed directive on the patentability of computer-related inventions are learning from their mistakes as they prepare for the possible resurrection of the issue. Lobbyists attending a Progress and Freedom Foundation (PFF) in Prague on 17 January signalled they will move early on the patent […]
Peru Attempts Strong WTO Position On Disclosure Despite Weaker US Deal 17/12/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment By Tove Iren S. Gerhardsen and William New Hong Kong – Peru appears to be taking a strong position in World Trade Organization negotiations in favour of the disclosure of origin of genetic material and traditional knowledge in patent applications despite having agreed to weaker terms in a bilateral trade deal with the United States […]
CBD Issues Subject Of Tough Negotiations At WTO 16/12/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment Hong Kong–Countries pushing for the launch of negotiations on the protection of biodiversity and traditional knowledge have been engaged in tough talks at the World Trade Organization ministerial in Hong Kong today. The countries, led by India and Brazil, are working to get language on the issue included in the text expected at the conclusion […]
India, Brazil Tie Biodiversity Negotiations To Doha Development Package 15/12/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch 2 Comments Hong Kong – At the World Trade Organization ministerial here, India has proposed the launch of negotiations on the disclosure of origin of material in patent applications, and says that if this issue is not addressed, there will be no development package in the outcome of the current round of trade talks at the WTO. […]
TRIPS Health Amendment Evokes Harsh NGO Reaction, Industry Caution 07/12/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment An amendment to a World Trade Organization agreement for public health purposes was harshly criticised by non-governmental organisations and greeted with caution by the pharmaceutical industry. NGOs said the access-to-medicines deal that was reached by WTO members on 6 December was hastily agreed and would make permanent a flawed agreement. It would make “access to […]
US, Andean Nations Narrow Differences On IP In Trade Talks 02/12/2005 by Martin Vaughan for Intellectual Property Watch 1 Comment By Martin Vaughan for Intellectual Property Watch Andean countries in late November narrowed differences with the United States over intellectual property protections in negotiations over a US-Andean bilateral free trade agreement, but divisions over market access for agriculture have likely delayed a final agreement until next year, at least for Colombia and Ecuador. Peruvian and […]
IP Experts Discuss Access To Pharmaceuticals In Developing Countries 27/11/2005 by William New, Intellectual Property Watch Leave a Comment Bern, Switzerland – A day-long conference of experts on health issues demonstrated the range of views in the debate on how developing countries should best address their public health needs through international policies. Dominique Sprumont of the University of Neuchâtel institut de droit de la santé, said the global push to arrange access to Tamiflu […]
TRIPS Council To Resume Talks On 29 November 25/11/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment The World Trade Organization next week will reconvene a suspended meeting on unresolved intellectual property issues that sources say have moved little in the final weeks before the 13-18 December ministerial in Hong Kong. The 29 November meeting will consider agenda items related to the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) […]
US Industry Group Seeks To Shift Geneva IP Debate 15/11/2005 by William New, Intellectual Property Watch 1 Comment Citing a need to change the debate on intellectual property issues, another US trade association has added Geneva to its list of lobbying stops. The Association for Competitive Technology (ACT) has expanded its presence in Europe in recent years mainly at the European Union level in Brussels. But now the group is turning its attention […]
Indian Industry Pushing for Compulsory Licenses for Tamiflu 25/10/2005 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment While Swiss-based Roche, the rights holder to the most-favoured medicine for avian influenza, is pursuing sub-licenses, India is moving ahead with exploring the option of compulsory licensing. If this goes through, India would be able to export Tamiflu to developing countries and certain developed countries. The Indian Cabinet is considering issuing compulsory licenses to local […]